Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
DarioHealth Corp (DRIO)
NASDAQ:DRIO
Holding DRIO?
Track your performance easily
Earnings Data
Report Date
Mar 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.33Last Year’s EPS
-$0.41Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: -17.10%
|Next Earnings Date:Mar 26, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong revenue growth, improvements in gross margins, and successful cost management, alongside strategic expansions and partnerships. While there are challenges in revenue realization from new clients and transitioning the pharma channel to stable revenue streams, the positive achievements outweigh the negatives.Company Guidance
In the DarioHealth Third Quarter 2024 earnings call, the company provided a detailed overview of its financial performance and strategic initiatives. DarioHealth reported a revenue of $7.42 million for Q3, marking an 18.7% increase over Q2 2024 and an impressive 111% year-over-year growth. The company achieved a gross margin of 83% in its B2B2C segment, with overall business gross margins at 70% on a non-GAAP basis. DarioHealth secured 10 new client contracts during the quarter and aims to add approximately 5 more by the end of the year, potentially bringing total client wins to between 17 and 20 for the second half of 2024. Operating expenses were reduced to $12.3 million, a 15.9% decline from the previous quarter, contributing to a significant decrease in net loss. The company is on track to achieve a cash flow breakeven run rate by the end of 2025, with projected reductions in non-GAAP operating losses by 69% from Q1 2024 to Q1 2025. Additionally, DarioHealth's strategic initiatives include expanding its client base, deepening client relationships, and transitioning its revenue model towards more stable and predictable streams, particularly in the pharma channel.Significant Revenue Growth
DarioHealth reported $7.42 million in revenue for Q3 2024, marking an 18.7% increase over Q2 2024 and an impressive 111% year-over-year growth.
High Gross Margins Achieved
Gross margins for the B2B2C business rose to 83%, with overall business gross margins reaching 70% on a non-GAAP basis.
Expansion of Client Base
The company secured 10 new client wins in Q3 2024 and expects to secure approximately 5 more by the end of the year, totaling 17-20 new clients for the second half of 2024.
Cost Management Success
Non-GAAP operating expenses were reduced to $12.3 million, a 15.9% sequential decline from Q2 2024, showcasing disciplined cost management.
Strategic Partnerships and Expansions
Major partnerships include a new contract with Centene in the Medicare Advantage market and a significant partnership with AARP, providing access to 38 million members.
Pharma Channel Progress
The company closed 2 new deals in the pharma channel, including a top 6 global pharmaceutical company, transitioning from milestone-based to recurring revenue.
---
DRIO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DRIO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $0.96 | $0.97 | +1.04% |
| Aug 08, 2024 | $0.93 | $0.83 | -10.75% |
| May 15, 2024 | $1.73 | $1.85 | +6.94% |
| Mar 28, 2024 | $1.52 | $1.53 | +0.66% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does DarioHealth Corp (DRIO) report earnings?
DarioHealth Corp (DRIO) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is DarioHealth Corp (DRIO) earnings time?
DarioHealth Corp (DRIO) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DRIO EPS forecast?
DRIO EPS forecast for the fiscal quarter 2024 (Q4) is -$0.33.
---